Compounds > busulfan

busulfan and leucine

busulfan has been researched along with leucine in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (16.67)	18.7374
1990's	3 (50.00)	18.2507
2000's	1 (16.67)	29.6817
2010's	1 (16.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY	1
Atkins, LM; Gale, GR; Smith, AB	1
Saito, Y; Usuka, Y	1
Saito, Y; Uzuka, Y	2
Fujimaki, K; Ishigatsubo, Y; Kanamori, H; Koharazawa, H; Taguchi, J; Takabayashi, M; Takasaki, H; Yamaji, S	1

Other Studies

6 other study(ies) available for busulfan and leucine

Article	Year
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10 Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding	2012
Comparative effects of Yoshi-864 and busulfan on certain transplantable murine tumors. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1975, Volume: 149, Issue:1 Topics: Alkylating Agents; Animals; Busulfan; Carcinoma, Ehrlich Tumor; Cell Survival; Chick Embryo; DNA Replication; Drug Evaluation, Preclinical; Humans; Infant, Newborn; Injections, Intraperitoneal; Leucine; Leukemia L1210; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Proteins; Neoplasm Transplantation; Thymidine; Transcription, Genetic; Transplantation, Homologous; Tritium; Uridine	1975
Bestatin treatment of myelodysplastic syndromes and chronic myelogenous leukemia. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 1991, Volume: 45, Issue:2-3 Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Busulfan; Drug Therapy, Combination; Female; Humans; Leucine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Myelodysplastic Syndromes	1991
[Combination therapy of chronic myelogenous leukemia with busulfan and bestatin]. Gan to kagaku ryoho. Cancer & chemotherapy, 1991, Volume: 18, Issue:4 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Female; Gene Rearrangement; Humans; Leucine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Remission Induction	1991
[Bestatin therapy of chronic myelogenous leukemia]. Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:2 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Female; Humans; Leucine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Accelerated Phase; Leukemia, Myeloid, Chronic-Phase; Male; Middle Aged; Remission Induction; Survival Rate	1993
Long-term cytogenetic remission with ubenimex monotherapy in a case of chronic myeloid leukemia. Anti-cancer drugs, 2004, Volume: 15, Issue:7 Topics: Aged; Bone Marrow Cells; Busulfan; Humans; Immunologic Factors; Leucine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Philadelphia Chromosome; Remission Induction; Time Factors	2004

chemdatabank.com